Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:MJN

Mead Johnson Nutrition (MJN) Stock Price, News & Analysis

Mead Johnson Nutrition logo

About Mead Johnson Nutrition Stock (NYSE:MJN)

Advanced Chart

Key Stats

Today's Range
$89.98
$89.98
50-Day Range
N/A
52-Week Range
$69.25
$94.40
Volume
N/A
Average Volume
3.24 million shs
Market Capitalization
N/A
P/E Ratio
24.25
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company marketed its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe, as of December 31, 2016.

Receive MJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mead Johnson Nutrition and its competitors with MarketBeat's FREE daily newsletter.

MJN Stock News Headlines

Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
Abbott, Mead Johnson secure win in infant formula trial, Reuters reports
See More Headlines

MJN Stock Analysis - Frequently Asked Questions

Mead Johnson Nutrition CO (NYSE:MJN) posted its quarterly earnings results on Thursday, April, 27th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.01. Mead Johnson Nutrition's revenue was down 8.2% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mead Johnson Nutrition investors own include Bristol-Myers Squibb (BMY), NVIDIA (NVDA), Ford Motor (F), Yum! Brands (YUM), Broadcom (BRCM), Caterpillar (CAT) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
4/27/2017
Today
5/04/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Packaged Foods & Meats
Current Symbol
NYSE:MJN
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
24.25
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:MJN) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners